Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-019219
Filing Date
2013-03-27
Accepted
2013-03-27 20:07:21
Documents
1
Period of Report
2013-03-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd374439.html 4  
1 FORM 4 rrd374439.xml 4 21589
  Complete submission text file 0001181431-13-019219.txt   22974
Mailing Address 125 UNIVERSITY AVE. C/O SKYLINE VENTURES PALO ALTO CA 94301
Business Address
Freund John Gordon (Reporting) CIK: 0001296771 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35837 | Film No.: 13721239

Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Issuer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations